Interesting article in the Australian today - ( "Biotechs feel ill as US counterparts take off") - Criterion- page 32. Begins as follows:
Like a dingo's wail across the valley on a still black night, the plaintive cry from the local biotech sector resonates clearly: why are we doing the same as our US peers but being valued at a fraction of their worth by the local market?
Where's the love?
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 93853 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 80000 | 1 |
View Market Depth
| Last trade - 09.59am 29/08/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable